227 related articles for article (PubMed ID: 29019447)
1. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.
Qunaj L; Castillo JJ; Olszewski AJ
Leuk Lymphoma; 2018 Jun; 59(6):1375-1383. PubMed ID: 29019447
[TBL] [Abstract][Full Text] [Related]
2. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].
Wang WY; Ma ZG; Li GD; Liu WP; Zhong L; Wang Y; Li JM; Li L; Jiang W; Tang Y; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):529-34. PubMed ID: 17134546
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphomas with plasmablastic differentiation.
Teruya-Feldstein J
Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
[TBL] [Abstract][Full Text] [Related]
4. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.
Beltran B; Castillo J; Salas R; Quiñones P; Morales D; Hurtado F; Riva L; Winer E
J Hematol Oncol; 2009 Feb; 2():11. PubMed ID: 19250532
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-Positive CD20- and CD45-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.
Starr A; Kwon DH; Kallakury B
Int J Surg Pathol; 2019 Feb; 27(1):98-101. PubMed ID: 29968492
[TBL] [Abstract][Full Text] [Related]
6. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
Castillo JJ; Chavez JC; Hernandez-Ilizaliturri FJ; Montes-Moreno S
Expert Rev Hematol; 2015 Jun; 8(3):343-54. PubMed ID: 25641215
[TBL] [Abstract][Full Text] [Related]
7. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
AbdullGaffar B; Seliem RM
Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
[TBL] [Abstract][Full Text] [Related]
8. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.
Li J; Zhao S; Wang J; Chen J; Wen W; Zhang Q
Tumour Biol; 2016 Mar; 37(3):3619-37. PubMed ID: 26459310
[TBL] [Abstract][Full Text] [Related]
9. Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab.
Rasheed AA; Samad A; Raheem A; Hirani SI; Shabbir- Moosajee M
Asian Pac J Cancer Prev; 2018 Feb; 19(2):331-335. PubMed ID: 29479962
[TBL] [Abstract][Full Text] [Related]
10. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.
Schommers P; Hentrich M; Hoffmann C; Gillor D; Zoufaly A; Jensen B; Bogner JR; Thoden J; Wasmuth JC; Wolf T; Oette M; Müller M; Esser S; Vehreschild JJ; Fätkenheuer G; Wyen C
Br J Haematol; 2015 Mar; 168(6):806-10. PubMed ID: 25403997
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience.
Salat H; Din NU; Moatter T; Kayani N; Ahmed A
Pathol Res Pract; 2017 Jun; 213(6):649-653. PubMed ID: 28551388
[TBL] [Abstract][Full Text] [Related]
12. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
[TBL] [Abstract][Full Text] [Related]
13. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
[TBL] [Abstract][Full Text] [Related]
14. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
15. CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: a matched case-control analysis in a single institution.
Li YJ; Li ZM; Rao HL; Xia Y; Huang HQ; Xia ZJ; Li S; Li WY; Jiang WQ
J Transl Med; 2012 May; 10():84. PubMed ID: 22554077
[TBL] [Abstract][Full Text] [Related]
16. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.
Teruya-Feldstein J; Chiao E; Filippa DA; Lin O; Comenzo R; Coleman M; Portlock C; Noy A
Ann Oncol; 2004 Nov; 15(11):1673-9. PubMed ID: 15520070
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin G; Butera JN
Leuk Lymphoma; 2010 Nov; 51(11):2047-53. PubMed ID: 20919850
[TBL] [Abstract][Full Text] [Related]
18. Unclassifiable CD20-negative Testicular Diffuse Large B-cell Lymphoma.
Garrido-Abad P; García-Martín L; Villar-Zarra K; Díaz-Menéndez A; Fernández-Arjona M
Urology; 2018 Jul; 117():e3-e4. PubMed ID: 29723590
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder.
Wang W; Kanagal-Shamanna R; Medeiros LJ
Histopathology; 2018 Apr; 72(5):855-861. PubMed ID: 29105119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
